Endo Sues Mylan Over Generic Lidoderm Patch
Mylan sent Endo a letter in January announcing that it was filing an abbreviated new drug application for a generic version of Lidoderm with the U.S. Food and Drug Administration, according to a complaint filed in the U.S. District Court for the District of Delaware.
The letter said the proposed generic lidocaine patch...
Already a subscriber? Click here to login